What is Nabla?
Headquartered in Paris, France, Nabla specializes in the development of sophisticated AI-powered tools designed to streamline the administrative burden on medical professionals. The company's core technology focuses on the automated generation of clinical notes derived from patient consultations, effectively bridging the gap between complex medical interactions and electronic health record management. By leveraging advanced natural language processing, Nabla enables physicians to prioritize patient care over manual documentation, thereby enhancing clinical efficiency and accuracy. This market position has made the firm a pivotal entity in the digital health transformation, particularly as healthcare systems globally seek to mitigate provider burnout through intelligent automation.
How much funding has Nabla raised?
Nabla has raised a total of $112.8M across 3 funding rounds:
Series A
$18.8M
Series B
$24M
Series C
$70M
Series A (2020): $18.8M, investors not publicly disclosed
Series B (2024): $24M led by Cathay Innovation and Zebox Ventures
Series C (2025): $70M supported by Cathay Innovation, Highland Europe, HV Capital, and BC Mgmt
Key Investors in Nabla
Cathay Innovation
A global venture capital firm that supports entrepreneurs by connecting them to a worldwide ecosystem, focusing on multi-stage startups that drive positive impact through technology.
Highland Europe
A growth-stage investment firm providing capital to product-led companies across software and consumer sectors in Europe and Israel, emphasizing founder-centric values.
HV Capital
An independent venture funding firm based in Germany that specializes in supporting companies during their early and growth stages of business development.
What's next for Nabla?
With the successful closure of this major strategic investment, Nabla is well-positioned to accelerate its international expansion and deepen its product capabilities. The company is expected to focus on scaling its enterprise-grade infrastructure to support larger hospital networks and integrated health systems. Future strategic initiatives will likely involve enhancing the interoperability of its AI models with existing legacy health record platforms, ensuring seamless integration into diverse clinical workflows. As the firm transitions into this mature growth stage, the focus will shift toward long-term sustainability and the refinement of its proprietary algorithms to meet the evolving regulatory and operational demands of the global healthcare market.
See full Nabla company page
